Ceftriaxone Impurity 2 | CAS 84994-24-1 - Request Quote
Ceftriaxone Impurity 2
| SZ CAT No: | SZ-C082008 |
| CAS No | 84994-24-1 |
| Mol.F. | C13H10N4O3S2 |
| Mol.Wt. | 334.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ceftriaxone Impurity 2 is chemically Benzo[d]thiazol-2-yl (Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetate. Ceftriaxone Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Ceftriaxone Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ceftriaxone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 84994-24-1
Purchase 84994-24-1
Order 84994-24-1
Enquire 84994-24-1
price of 84994-24-1
84994-24-1 Supplier
84994-24-1 Manufacturer
84994-24-1 Exporter
buy high quality Ceftriaxone Impurity 2
Purchase Ceftriaxone Impurity 2
Ceftriaxone Impurity 2 suppliers
Ceftriaxone Impurity 2 manufacturers
Ceftriaxone Impurity 2 price
Order Ceftriaxone Impurity 2
Enquire Ceftriaxone Impurity 2
Ceftriaxone Impurity 2 cost
Ceftriaxone Impurity 2 Supplier
Ceftriaxone Impurity 2 Distributor
Ceftriaxone Impurity 2 for Method Validation
Ceftriaxone Reference Standard
Ceftriaxone Impurity 2 for ANDA Filing
Ceftriaxone Impurity 2 for Forced Degradation Studies
Ceftriaxone Impurity 2 Identification Standards
Ceftriaxone Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.